Atjaunināt sīkdatņu piekrišanu

Psychopharmacology: A mental health professionals guide to commonly used medications 2nd edition [Mīkstie vāki]

  • Formāts: Paperback / softback, 328 pages, height x width x depth: 234x156x17 mm, weight: 610 g
  • Sērija : Nursing
  • Izdošanas datums: 13-Sep-2021
  • Izdevniecība: Critical Publishing Ltd
  • ISBN-10: 1914171446
  • ISBN-13: 9781914171444
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 35,20 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
Psychopharmacology: A mental health professionals guide to commonly used medications 2nd editionPalielināt
  • Formāts: Paperback / softback, 328 pages, height x width x depth: 234x156x17 mm, weight: 610 g
  • Sērija : Nursing
  • Izdošanas datums: 13-Sep-2021
  • Izdevniecība: Critical Publishing Ltd
  • ISBN-10: 1914171446
  • ISBN-13: 9781914171444
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781914171444.html
Keywords:

An updated and revised edition of this accessible best-selling text suitable for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes.



This jargon-free guide is suitable for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes. A life-saving book that you can carry anywhere you go!

Introductory material provides a background on psychotropic drugs, the etiology of mental illness, some of the commonly used drugs in practice and brief notes on common non-pharmacological interventional options. It also examines the pathophysiology of mental illness and clinical decision making.

The central chapters provide comprehensive coverage of all the major medications used in the most common mental health disorders, detailing key drugs and including side effects, average doses, contra-indications and precautions, and clinical management interventions. Case studies, multiple choice questions and summary tasks in each chapter enable readers to clearly relate theory to practice and thoroughly review their learning.

The second edition of this best-selling text has been completely revised to include:

  • updated information and refreshed case studies throughout;
  • more activities for self-study and interactive learning, including multiple choice questions;
  • an emphasis on new ways of working within mental health settings, such as non-restrictive practice;
  • a completely new chapter on alcohol and substance misuse.

Recenzijas

I would recommend this book to all mental health nurse prescribers, nurses and students. The book layout is brilliant with a concise summary and questions at the end of each chapter, which makes the reader reflect on the content read in each chapter. A very well written and a very useful resource for practitioners and learners.

Dr Geeta Patel (GP with specialist interest in psychiatry)

Meet the author vii
Acknowledgements viii
Foreword ix
Praise for the first edition xi
Introduction 1(3)
The structure of this book
2(1)
Learning features
2(2)
1 Mental Illness
4(24)
1.1 Introduction
4(2)
1.2 Aetiology of mental illness
6(2)
1.3 Neurodevelopmental theories
8(5)
Neurons and neurotransmitters
8(5)
1.4 Clinical decision making in practice, and medicine management and optimisation
13(15)
Psychosocial interventions in mental health settings
20(8)
2 Drugs Used In Psychoses
28(69)
2.1 Introduction
28(3)
Severe mental illness
28(1)
Schizophrenia
29(2)
2.2 Mechanism of action
31(12)
Biochemical theories
32(3)
Typical antipsychotics
35(2)
Atypical antipsychotics
37(6)
2.3 Dose and administration
43(21)
Rapid tranquillisation
43(8)
Non-restrictive interventions
51(3)
An tipsychotic drugs in depot preparation
54(5)
Cytochrome P450 drug-metabolising enzymes interaction with psychotropics
59(5)
2.4 Adverse effects and management
64(28)
Extrapyramidal side effects
64(2)
Akathisia
66(1)
Drug-induced parkinsonism
67(2)
Tardive dyskinesia
69(2)
Anticholinergic drugs
71(1)
Non-extrapyramidal adverse effects of antipsychotic drugs
72(10)
Allergic and dermatological effects
82(1)
Haematological adverse effects
83(1)
Obligatory monitoring for clozapine therapy
84(2)
Neuroleptic malignant syndrome
86(2)
Improving physical health needs in SMI: best practice monitoring
88(2)
Behavioural change initiatives alongside routine physical health monitoring
90(1)
Lester Cardiometabolic Tool
90(1)
National Early Warning Score 2 (NEWS 2)
91(1)
QRISK®3
91(1)
2.5 Medication adherence in mental health settings
92(5)
3 Drugs Used In Depression
97(35)
3.1 Introduction
97(10)
ICD-11: key changes in relation to depression diagnostic criteria
99(1)
Screening for depression and anxiety in primary care settings
100(1)
Co-morbid psychiatric presentations
101(2)
Key points about assessment and management of symptoms of depression and anxiety in primary care
103(4)
3.2 Mechanism of action
107(3)
Monoamine theory of depression
107(3)
3.3 Dose and administration
110(6)
3.4 Adverse effects and management
116(11)
Tricyclic antidepressants
116(2)
Selective serotonin reuptake inhibitors
118(3)
Serotonin-noradrenaline reuptake inhibitors
121(1)
Tetracyclic (noradrenergic and specific serotonergic antidepressants)
122(1)
Aminoketone (bupropion)
123(1)
Monoamine oxidase inhibitors
124(2)
Serotonin syndrome
126(1)
3.5 Differences in therapeutic effects of antidepressants
127(5)
4 Drugs Used In Dementia
132(15)
4.1 Introduction
132(2)
Dementia assessment and diagnosis: best practice
133(1)
4.2 Mechanism of action
134(2)
Acetylcholinesterase inhibitors
134(2)
4.3 Dose and administration
136(1)
4.4 Adverse effects and management
137(3)
Acetylcholinesterase inhibitors
137(1)
Cholinergic crisis
138(1)
Polypharmacy in the older person
139(1)
Antipsychotic therapy in the care of the older person
140(1)
4.5 Memantine (NMDA receptor antagonist)
140(7)
Mechanism of action
140(1)
Concomitant use of cholinesterase inhibitors and memantine
141(1)
Adverse effects and management of memantine
141(6)
5 Drugs Used In Bipolar Disorder
147(24)
5.1 Introduction
147(4)
The aetiology of bipolar disorder
148(1)
Bipolar disorder clinical presentation and management
149(2)
5.2 Mechanism of action
151(1)
5.3 Dose and administration
152(6)
Lithium
153(2)
Valproate
155(1)
Carbamazepine
156(1)
Lamotrigine
157(1)
5.4 Adverse effects, monitoring and management
158(13)
Lithium
158(4)
Valproate
162(2)
Carbamazepine
164(2)
Lamotrigine
166(5)
6 Drugs Used In Anxiety Disorders
171(21)
6.1 Introduction
171(3)
Types of anxiety
172(2)
6.2 Mechanism of action
174(4)
Benzodiazepine hypnotics and anxiolytics
174(1)
Non-benzodiazepine hypnotics
175(1)
Melatonin
176(1)
Non-benzodiazepine anxiolytics
176(2)
6.3 Dose and administration
178(2)
6.4 Adverse effects and management
180(12)
Adverse effects of benzodiazepines
180(1)
Withdrawal from benzodiazepines
181(1)
Risk of overdose with benzodiazepines
182(1)
Adverse effects of non-benzodiazepine hypnotics (Z-drugs)
183(4)
Adverse effects of non-benzodiazepine anxiolytics
187(5)
7 Drugs Used In Alcohol And Substance Misuse
192(56)
7.1 Introduction
192(3)
7.2 Most vulnerable groups to substance use disorders
195(1)
7.3 The mesolimbic dopamine circuit as the key reward pathway component
196(3)
How does cocaine and methamphetamine use affect the functioning of the reward circuit?
198(1)
7.4 Drug tolerance, dependence, addiction
199(3)
Tolerance
199(1)
Dependence
200(1)
Addiction
201(1)
7.5 The psychopharmacology of commonly used drug substances and their effects
202(17)
Club (party) drugs
202(17)
7.6 Care planning and management of substance misuse disorders
219(4)
7.7 Medications used to treat alcohol dependence, smoking cessation and other drug dependencies
223(25)
Drug-related deaths
235(2)
Severe mental illness and smoking cessation
237(11)
Appendix: Answers to chapter review questions and MCQs 248(29)
Glossary 277(10)
References 287(22)
Index 309
Herbert Mwebe is an Associate Professor of Mental Health and a Senior Teaching Fellow, leading a team of mental health nurse academics. Herbert 's teaching and research interests focus on best practice relating to parity of esteem, with reference to improving physical health outcomes in SMI, appropriate, safe, and effective use of psychopharmacological agents, and recovery approaches. He has worked in various higher education and NHS settings, including general practice, secondary and primary care services. He is a specialist clinical advisor to the CQC, supporting with inspections of community and hospital mental health settings. He sits on His Majesty's Courts and Tribunal Service - The First Tier-Mental Health Review Tribunal as a Specialist Panel Member. He is an editorial board member for the British of Journal of Mental Health Nursing and an external examiner at Bournemouth University on a range of CPD modules. He is a peer reviewer for various journals including Mental Health Practice (RCNi). Herbert is a co-director and lead for Education and Training for a CIC diaspora health association, Uganda Nurses, and Midwives Association UK.